AmyElizabethArmstrongMD

PubMed

• Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
  Stein, M., Patel, P. A., Zhiguo Zhao, Pratik A Patel, Leonora Slatnick, Anna Sitthi-Amorn, Kevin J Bielamowicz, Farranaz A Nunez, Alexandria M Walsh, Jennifer Hess, Je...> ;Journal of Clinical Oncology. 2024 Mar 1
• 2 citations
  Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
  Carina A Dehner, Robert C Bell, Yang Cao, Kevin He, John S A Chrisinger, Amy E Armstrong, Marielle Yohe, Jack Shern, Angela C Hirbe> ;JCO Precision Oncology. 2023 Sep 1
• Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma.
  Anna C Suydam, Alicia Bach, Stephanie Markovina, Perry Grigsby, Jennifer Sprague, Amy E Armstrong> ;Journal of Pediatric Hematology/oncology. 2023 Nov 1
• 4 citations
  Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.
  Amy E Armstrong, Allan J Belzberg, John R Crawford, Angela C Hirbe, Zhihong J Wang> ;BMC Cancer. 2023 Jun 16
• 4 citations
  Advances in the clinical management of high-risk Wilms tumors.
  Michael V Ortiz, Christa Koenig, Amy E Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M C Mavinkurve-Groothuis, Thelma B Velasquez Herrera, Rajkumar Venkatramani...> ;Pediatric Blood & Cancer. 2023 May 1
• 1 citations
  Lorlatinib use in an infant with thalamic ALK-positive histiocytosis.
  Irem Eldem, Jennifer Picarsic, Ashish Kumar, Yaël P Mossé, Kaleigh Filisa Roberts, Amy E Armstrong, Bryan A Sisk> ;Pediatric Blood & Cancer. 2023 Apr 19
• 2 citations
  Advances in the clinical management of high-risk Wilms tumors.
  Michael V Ortiz, Christa Koenig, Amy E Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M C Mavinkurve-Groothuis, Thelma B Velasquez Herrera, Rajkumar Venkatramani...> ;Pediatric Blood & Cancer. 2023 Mar 1
• 35 citations
  Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
  Ami V Desai, Giles W Robinson, Karen Gauvain, Ellen M Basu, Margaret E Macy, Luke Maese, Nicholas S Whipple, Amit J Sabnis, Jennifer H Foster, Suzanne Shusterman, Jane...> ;Neuro-Oncology. 2022 Oct 3
• 2 citations
  A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.
  Simge Acar, Edwin Nieblas-Bedolla, Amy E Armstrong, Angela C Hirbe> ;Pediatric Neurology. 2022 Sep 1
• 1 citations
  Plexiform neurofibroma: shedding light on the investigational agents in clinical trials.
  Simge Acar, Amy E Armstrong, Angela C Hirbe> ;Expert Opinion on Investigational Drugs. 2022 Jan 1
• 11 citations
  Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma
  Carina Dehner, Amy E. Armstrong, Marielle E. Yohe, Jack F. Shern, Angela C. Hirbe> ;Genes. 2021 Sep 25
• 33 citations
  Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
  Michael Fisher, Chie-Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffre...> ;Nature Medicine. 2021 Jan 13
• 2 citations
  Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy.
  Dana Sous, Amy E. Armstrong, Jennifer T. Huang, Sonal Shah, Valerie M. Carlberg, Carrie C. Coughlin> ;Pediatric Dermatology. 2021 Jan 1
• 2 citations
  Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromat...
  Amy E. Armstrong, Steven D. Rhodes, Abbi Smith, Shi Chen, Waylan K. Bessler, Michael J. Ferguson, Li Jiang, Xiaohong Li, Jin Yuan, Xianlin Yang, Feng-Chun Yang, Kent A...> ;Pediatric Blood & Cancer. 2020 Aug 1
• 5 citations
  Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape.
  Amy E. Armstrong, Nicole M. Brossier, Angela C. Hirbe> ;The Lancet. Child & Adolescent Health. 2020 Jul 1
• 41 citations
  Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
  Steven D. Rhodes, Yongzheng He, Abbi Smith, Li Jiang, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan K. Bessler, Shaomin Qian, William Dyer, George E. Sandusky, Andrew ...> ;Human Molecular Genetics. 2019 Aug 15
• 80 citations
  Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center Experience
  Jenna Rossoff, Sonali Chaudhury, Maulin Soneji, Sameer J. Patel, Soyang Kwon, Amy E. Armstrong, William J. Muller> ;Open Forum Infectious Diseases. 2019 Aug 1
• 57 citations
  Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for in...
  Amy E. Armstrong, Jenna Rossoff, Desiree Hollemon, David K. Hong, William J. Muller, Sonali Chaudhury> ;Pediatric Blood & Cancer. 2019 Jul 1
• 15 citations
  5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype
  Mark A. Applebaum, Erin K. Barr, Jason Karpus, Ji Nie, Zhou Zhang, Amy E. Armstrong, Sakshi Uppal, Madina Sukhanova, Wei Zhang, Alexandre Chlenski, Helen R. Salwen, Em...> ;JCO Precision Oncology. 2019 May 16
• 6 citations
  Prolonged response to sorafenib in a patient with refractory metastatic osteosarcoma and a somatic PDGFRA D846V mutation.
  Amy E. Armstrong, David O. Walterhouse, Patrick J. Leavey, Jennifer Reichek, Amy L. Walz> ;Pediatric Blood & Cancer. 2019 Jan 1
• 33 citations
  A unique subset of low-risk wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A children’s oncology group...
  Amy E. Armstrong, Samantha Gadd, Vicki Huff, Daniela S. Gerhard, Jeffrey S. Dome, Elizabeth J. Perlman> ;Plos One. 2018 Dec 13
• 6 citations
  Proximal Hypospadias and a Novel WT1 Variant: When Should Genetic Testing Be Considered?
  Elizabeth Dabrowski, Amy E. Armstrong, Elizabeth A. Leeth, Emilie K. Johnson, Earl Y. Cheng, Yasmin Gosiengfiao, Courtney Finlayson> ;Pediatrics. 2018 Apr 1
• 3 citations
  Current Knowledge and Practice of Pediatric Providers in Umbilical Cord Blood Banking.
  Amy E. Armstrong, Rachel Fonstad, Stephen R. Spellman, Zoe Tullius, Sonali Chaudhury> ;Clinical Pediatrics. 2018 Feb 1
• 210 citations
  A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
  Samantha Gadd, Vicki Huff, Amy L. Walz, Ariadne H. A. G. Ooms, Amy E. Armstrong, Daniela S. Gerhard, Malcolm A. Smith, Jaime M. Guidry Auvil, Daoud Meerzaman, Qing Ron...> ;Nature Genetics. 2017 Aug 21
• 20 citations
  Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Auto...
  Amy E. Armstrong, Karina Danner-Koptik, Shannon Golden, Jennifer Schneiderman, Morris Kletzel, Jennifer Reichek, Yasmin Gosiengfiao> ;Journal of Pediatric Hematology/oncology. 2017 May 1
• Join now to see all